Gufic Biosciences Ltd GUFICBIO-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 08/03/21 IST
192.00UNCH (UNCH)
52 week range
76.20 - 215.95

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close192.00
  • 52 Week High215.95
  • 52 Week High Date05/17/21
  • 52 Week Low76.20
  • 52 Week Low Date09/22/20

Key Stats

  • Market Cap192.72M
  • Shares Out77.83M
  • 10 Day Average Volume229,805.2
  • Dividend0.05
  • Dividend Yield0.03%
  • Beta-
  • YTD % Change58.87

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close192.00
  • 52 Week High215.95
  • 52 Week High Date05/17/21
  • 52 Week Low76.20
  • 52 Week Low Date09/22/20
  • Market Cap192.72M
  • Shares Out77.83M
  • 10 Day Average Volume229,805.2
  • Dividend0.05
  • Dividend Yield0.03%
  • Beta-
  • YTD % Change58.87

RATIOS/PROFITABILITY

  • EPS (TTM)4.55
  • P/E (TTM)42.20
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date11/03/2020
  • Div Amount0.05
  • Split Date-
  • Split Factor-

Latest On Gufic Biosciences Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products. The Company's segments include Pharma, including Formulations and Bulk Drugs, and Consumer. It has pharmaceutical products under categories, such as Criti Care, including Doxific, Micafung, Rabol and Tigefic-Plus; Criticare Life, including Ticofic-200 and Gufivan-500; Ferticare, including Puregraf 75IU 3D, Cetrocare 0.25mg 3D and Follicare 150IU 3D; Spark...
Jayesh Choksi
Chairman
Pranav Choksi
Chief Executive Officer
Devkinandan Roonghta
Chief Financial Officer
Address
Gufic House
Sobhash Road, Vile Parle East
Mumbai
400057
India